Rhumbline Advisers Avita Medical, Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Avita Medical, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 38,775 shares of RCEL stock, worth $357,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,775
Previous 35,327
9.76%
Holding current value
$357,117
Previous $452,000
23.23%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCEL
# of Institutions
76Shares Held
6.31MCall Options Held
28.8KPut Options Held
17.2K-
Black Rock Inc. New York, NY1.78MShares$16.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$13.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA598KShares$5.5 Million0.0% of portfolio
-
State Street Corp Boston, MA535KShares$4.93 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA261KShares$2.41 Million0.65% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $231M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...